165 related articles for article (PubMed ID: 1639340)
1. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
Sahlin S; Ahlberg J; Reihnér E; Ståhlberg D; Einarsson K
Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol metabolism in liver and gallbladder mucosa of patients with cholesterolosis.
Sahlin S; Ståhlberg D; Einarsson K
Hepatology; 1995 May; 21(5):1269-75. PubMed ID: 7737633
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
4. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
6. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
[TBL] [Abstract][Full Text] [Related]
7. Hepatic cholesterol metabolism in cholesterol gallstone disease.
Reihnér E; Angelin B; Björkhem I; Einarsson K
J Lipid Res; 1991 Mar; 32(3):469-75. PubMed ID: 2066675
[TBL] [Abstract][Full Text] [Related]
8. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
9. Hepatic cholesterol metabolism in estrogen-treated men.
Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K
Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886
[TBL] [Abstract][Full Text] [Related]
10. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids.
Maton PN; Ellis HJ; Higgins MJ; Dowling RH
Eur J Clin Invest; 1980 Aug; 10(4):325-32. PubMed ID: 6775960
[TBL] [Abstract][Full Text] [Related]
11. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH
Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
[TBL] [Abstract][Full Text] [Related]
13. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
[TBL] [Abstract][Full Text] [Related]
14. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
15. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism.
Einarsson K
Scand J Gastroenterol Suppl; 1994; 204():19-23. PubMed ID: 7824873
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
Nilsell K; Angelin B; Leijd B; Einarsson K
Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol, bile acid, and lipoprotein metabolism in two strains of hamster, one resistant, the other sensitive (LPN) to sucrose-induced cholelithiasis.
Férézou J; Combettes-Souverain M; Souidi M; Smith JL; Boehler N; Milliat F; Eckhardt E; Blanchard G; Riottot M; Sérougne C; Lutton C
J Lipid Res; 2000 Dec; 41(12):2042-54. PubMed ID: 11108738
[TBL] [Abstract][Full Text] [Related]
18. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
